Skip to main content
Premium Trial:

Request an Annual Quote

Looking at the Bigger Picture

An article in Tech Review covers a new screening approach that the Broad is trying out to screen drugs that affect leukemic stem cells. Instead of just screening the cells, they've added surrounding, or stromal, cells to the mix. "Cancer cells don't exist in isolation," says Kimberly Hartwell, a research fellow at Brigham and Women's Hospital, who helped lead the project. In tissues, these cells "may hijack the support system -- what we call the stromal cells."

The Scan

Could Cost Billions

NBC News reports that the new Alzheimer's disease drug from Biogen could cost Medicare in the US billions of dollars.

Not Quite Sent

The Biden Administration likely won't meet its goal of sending 80 million SARS-CoV-2 vaccine doses abroad by the end of the month, according to the Washington Post.

DTC Regulation Proposals

A new report calls on UK policymakers to review direct-to-consumer genetic testing regulations, the Independent reports.

PNAS Papers on Mosquito MicroRNAs, Acute Kidney Injury, Trichothiodystrophy

In PNAS this week: microRNAs involved in Aedes aegypti reproduction, proximal tubule cell response to kidney injury, and more.